APYX MEDICAL CORPORATION's ticker is APYX and the CUSIP is 03837C106. A total of 65 filers reported holding APYX MEDICAL CORPORATION in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $51,018 | +212.4% | 15,943 | +391.0% | 0.00% | +100.0% |
| Q2 2023 | $16,332 | -49.0% | 3,247 | -54.6% | 0.00% | 0.0% |
| Q3 2022 | $32,000 | +3100.0% | 7,147 | +3565.1% | 0.00% | – |
| Q2 2022 | $1,000 | -97.4% | 195 | -96.7% | 0.00% | – |
| Q1 2022 | $39,000 | +200.0% | 5,988 | +471.4% | 0.00% | – |
| Q4 2021 | $13,000 | -40.9% | 1,048 | -34.0% | 0.00% | -100.0% |
| Q3 2021 | $22,000 | -47.6% | 1,587 | -61.2% | 0.00% | 0.0% |
| Q2 2021 | $42,000 | +121.1% | 4,093 | +112.3% | 0.00% | – |
| Q1 2021 | $19,000 | -82.7% | 1,928 | -87.4% | 0.00% | -100.0% |
| Q4 2020 | $110,000 | -39.9% | 15,328 | -60.6% | 0.00% | +50.0% |
| Q3 2020 | $183,000 | +335.7% | 38,865 | +415.5% | 0.00% | 0.0% |
| Q2 2020 | $42,000 | +425.0% | 7,540 | +242.1% | 0.00% | – |
| Q1 2020 | $8,000 | -38.5% | 2,204 | +18.2% | 0.00% | -100.0% |
| Q3 2019 | $13,000 | +550.0% | 1,864 | +592.9% | 0.00% | – |
| Q2 2019 | $2,000 | – | 269 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Archon Capital Management LLC | 2,502,077 | $18,015,000 | 3.11% |
| Taylor Frigon Capital Management LLC | 621,056 | $4,472,000 | 1.47% |
| Millrace Asset Group, Inc. | 166,536 | $1,199,000 | 0.83% |
| Cowen Prime Services LLC | 235,959 | $1,699,000 | 0.75% |
| Lighthouse Financial Advisors, Inc. | 172,598 | $1,242,000 | 0.42% |
| RTW INVESTMENTS, LP | 3,391,279 | $24,417,000 | 0.41% |
| WOLFF WIESE MAGANA LLC | 65,452 | $471,000 | 0.40% |
| COWEN AND COMPANY, LLC | 503,081 | $3,622,000 | 0.32% |
| PURA VIDA INVESTMENTS, LLC | 902,847 | $6,501,000 | 0.24% |
| WHITE PINE CAPITAL LLC | 81,489 | $587,000 | 0.21% |